$24.28
-0.29-1.18%
In chiusura: Sep 4, 5:00 PM EST
$24.08
-0.20-0.83%
Post-mercato: 5:24 PM EST
Adaptive Biotechnologies Corp
ADPTNASDAQ
Adaptive Biotechnologies Earnings & Forecasts
Adaptive Biotechnologies (ADPT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Adaptive Biotechnologies Guidance
Adaptive Biotechnologies (ADPT) ha pubblicato l'ultima guidance il gennaio 12, 2026 per fiscal year 2025. La società ha previsto un fatturato pari a $277M - $277M per il periodo.
Rispetto alle previsioni precedenti, Adaptive Biotechnologies {{epsDirection}} ha modificato le sue previsioni di fatturato da un intervallo precedente di {{epsPriorRange}}.
Adaptive Biotechnologies ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Adaptive Biotechnologies. 9
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.13 | $-0.16 | $-0.19 | $-0.15 |
| Actual | $-0.10 | $-0.13 | $-0.09 | $-0.15 |
| Surprise | +23.1% | +18.8% | +52.6% | 0.00% |
| Revenue | ||||
| Estimate | $66.1M | $61.1M | $60.9M | $66.0M |
| Actual | $71.6M | $70.9M | $71.7M | $60.2M |
| Surprise | +8.29% | +16.1% | +17.7% | -8.78% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.10 | $-0.06 | $-0.08 | $-0.05 |
| Revenue | ||||
| Consensus | $71.8M | $79.1M | — | — |